Obesity is often described as a “lifestyle disease,” with responsibility placed on individuals and their supposed lack of willpower. But eating habits are strongly shaped by the food environment: what is available, how much it costs, how products are marketed, where shops are located and which choices are most convenient. In many high-income countries, cheap, energy-dense foods are widely accessible, making healthier choices difficult. Changes in food demand—including those associated with GLP-1 weight-loss drugs—could therefore affect not only human health, but also agriculture, land use and the environment.
The UK Government’s national food strategy, finalized in 2021, makes a similar point. Improving diets is not simply a matter of asking individuals to make better decisions. The wider food environment must also change so that healthier choices become easier and more affordable.
These findings should not be interpreted as suggesting that people living with obesity are responsible for losing weight to reduce the environmental impact of food production. Instead, the research examines how changes in food demand could affect the food system as a whole.
Changing the food system with medicine
Eating more healthily does not necessarily mean consuming fewer calories. It can involve eating more fruit, vegetables and other nutritious foods, while reducing overconsumption of foods associated with poor health. Such changes can influence human health as well as farming, land use and the environment.
Rather than asking whether GLP-1 drugs or a healthier diet is the answer, it may be more useful to consider how the two could work together. A healthier food system would make nutritious foods available at affordable prices, reduce the relentless promotion of unhealthy options, support nutritious and sustainable agricultural production, and ensure that people who need it can access health care. Together, these measures could be more effective than any single intervention.
GLP-1 drugs may have an important role in addressing obesity, but they should not become a technological solution that lets society avoid examining the broader food system. These medicines may help people eat less in an unhealthy food environment, but the long-term goal should be to make healthier and more sustainable eating easier and more affordable.
The significance of GLP-1 drugs may not be limited to the amount of food people eat. They may also highlight how closely human health, food production and environmental health are connected—and how much could be achieved by addressing all three together.
Roslyn Henry is a lecturer in the Faculty of Biological Sciences at the University of Aberdeen. Peter Alexander is a professor of global food systems at the University of Edinburgh.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Source: arstechnica.com


